PUBLISHER: Grand View Research | PRODUCT CODE: 1726203
PUBLISHER: Grand View Research | PRODUCT CODE: 1726203
U.S. Nootropics Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Form (Powder, Drinks, Gummies), By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2030
U.S. Nootropics Market Growth & Trends:
The U.S. nootropics market size is estimated to reach USD 4.68 billion in 2030, growing at a CAGR of 9.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base.
Natural products held a major share in 2024. This is due to consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of "natural" with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies.
The drinks segment held the largest share in 2024.This can be attributed to their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate into daily routines, offering an easily consumable format compared to capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format also allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal to a wider consumer base.
Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers to competitive academic pursuits. Individuals are actively seeking solutions to improve focus, memory, attention span, and learning capabilities to gain a competitive edge and enhance productivity.
Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market.
U.S. Nootropics Market Report Highlights:
- Based on product, the synthetic segment is estimated to grow at a substantial CAGR over the forecast period. The capacity for targeted cognitive enhancement and precise formulations have stimulated the growth. Ongoing research enables the development of novel synthetic compounds with specific mechanisms of action and enhanced potency compared to natural extracts. Synthetic production allows for greater control over purity and consistency, potentially leading to more predictable and reliable effects, appealing to users seeking optimized and tailored cognitive benefits.
- Based on form, the gummies segment is anticipated to grow at a significant CAGR over the forecast period, driven by the appealing and convenient format of gummies. Gummies offer a palatable and enjoyable consumption experience, masking the potential bitterness of ingredients and resembling popular confectionery.
- Based on application, the sleep optimization segment is anticipated to grow at a faster CAGR over the forecast period. The increasing recognition of sleep's crucial role in cognitive function and overall well-being and rising rates of sleep disorders and stress-induced sleep issues are driving demand for natural sleep aids.
- Based on distribution channel, the online segment is anticipated to grow at a faster CAGR over the forecast period due to enhanced accessibility and convenience. They offer a wider selection of nootropics compared to brick-and-mortar stores, often at competitive prices due to reduced overhead.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Product Outlook
- 2.3. Form Outlook
- 2.4. Application Outlook
- 2.5. Distribution Channel Outlook
Chapter 3. U.S. Nootropics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Raw Material Outlook
- 3.2.2. Manufacturing & Technology Outlook
- 3.2.3. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis - Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis
- 4.1. U.S. Nootropics Market, By Product: Key Takeaways
- 4.2. Product Movement Analysis & Market Share, 2024 & 2030
- 4.3. Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
- 4.3.1. Natural
- 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.2. Synthetic
- 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1. Natural
Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis
- 5.1. U.S. Nootropics Market, By Form: Key Takeaways
- 5.2. Form Movement Analysis & Market Share, 2024 & 2030
- 5.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
- 5.3.1. Capsules/Tablets
- 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2. Powder
- 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.3. Drinks
- 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.4. Gummies
- 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.5. Others (Liquid, patches, and novel delivery methods)
- 5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.1. Capsules/Tablets
Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis
- 6.1. U.S. Nootropics Market, By Application: Key Takeaways
- 6.2. Application Movement Analysis & Market Share, 2024 & 2030
- 6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Million)
- 6.3.1. Cognitive Enhance
- 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2. Mood & Stress Management
- 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Sleep Optimization
- 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4. Energy & Physical Performance
- 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)
- 6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.1. Cognitive Enhance
Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis
- 7.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
- 7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 7.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
- 7.3.1. Offline
- 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2. Online
- 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.1. Offline
Chapter 8. Competitive Analysis
- 8.1. Recent developments & impact analysis, by key market participants
- 8.2. Company Categorization
- 8.3. Participant's Overview
- 8.4. Financial Performance
- 8.5. Product Benchmarking
- 8.6. Company Market Share Analysis, 2024 (%)
- 8.7. Company Heat Map Analysis
- 8.8. Strategy Mapping
- 8.9. Company Profiles
- 8.9.1. Qualia Life Sciences, LLC
- 8.9.1.1. Company Overview
- 8.9.1.2. Financial Performance
- 8.9.1.3. Product Portfolios
- 8.9.1.4. Strategic Initiatives
- 8.9.2. Unilever (Onnit Labs, Inc.)
- 8.9.2.1. Company Overview
- 8.9.2.2. Financial Performance
- 8.9.2.3. Product Portfolios
- 8.9.2.4. Strategic Initiatives
- 8.9.3. GNC Holdings, LLC
- 8.9.3.1. Company Overview
- 8.9.3.2. Financial Performance
- 8.9.3.3. Product Portfolios
- 8.9.3.4. Strategic Initiatives
- 8.9.4. Performance Lab USA Corp.
- 8.9.4.1. Company Overview
- 8.9.4.2. Financial Performance
- 8.9.4.3. Product Portfolios
- 8.9.4.4. Strategic Initiatives
- 8.9.5. NeuroGum, Inc.
- 8.9.5.1. Company Overview
- 8.9.5.2. Financial Performance
- 8.9.5.3. Product Portfolios
- 8.9.5.4. Strategic Initiatives
- 8.9.6. Natural Stacks
- 8.9.6.1. Company Overview
- 8.9.6.2. Financial Performance
- 8.9.6.3. Product Portfolios
- 8.9.6.4. Strategic Initiatives
- 8.9.7. Nootropics Depot
- 8.9.7.1. Company Overview
- 8.9.7.2. Financial Performance
- 8.9.7.3. Product Portfolios
- 8.9.7.4. Strategic Initiatives
- 8.9.8. BrainMD Health
- 8.9.8.1. Company Overview
- 8.9.8.2. Financial Performance
- 8.9.8.3. Product Portfolios
- 8.9.8.4. Strategic Initiatives
- 8.9.9. Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC)
- 8.9.9.1. Company Overview
- 8.9.9.2. Financial Performance
- 8.9.9.3. Product Portfolios
- 8.9.9.4. Strategic Initiatives
- 8.9.10. NOW Foods.
- 8.9.10.1. Company Overview
- 8.9.10.2. Financial Performance
- 8.9.10.3. Product Portfolios
- 8.9.10.4. Strategic Initiatives
- 8.9.1. Qualia Life Sciences, LLC
List of Tables
- Table 1 U.S. nootropics market - Key market driver analysis
- Table 2 U.S. nootropics market - Key market restraint analysis
- Table 3 U.S. nootropics market estimates & forecast, by product (USD Million)
- Table 4 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 5 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 6 U.S. Nootropics market estimates & forecast, by form (USD Million)
- Table 7 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 8 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 9 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 10 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 11 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 12 U.S Nootropics market estimates & forecast, by application (USD Million)
- Table 13 U.S. Cognitive Enhance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 14 U.S. Mood & Stress Management nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 15 U.S. Sleep Optimization nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 16 U.S. Energy & Physical Performance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 17 U.S. others market estimates and forecast, 2018 - 2030 (USD Million)
- Table 18 U.S. nootropics market estimates & forecast, by distribution channel (USD Million)
- Table 19 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Table 20 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 U.S. Noottopics market snapshot
- Fig. 2 U.S. Nootropics market segmentation & scope
- Fig. 3 U.S. Nootropics market penetration & growth prospect mapping
- Fig. 4 U.S. Nootropics market value chain analysis
- Fig. 5 U.S. Nootropics market dynamics
- Fig. 6 U.S. Nootropics market Porter's Five Forces analysis
- Fig. 7 U.S. Nootropics market: Product movement analysis, 2024 & 2030 (%)
- Fig. 8 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 9 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 10 U.S. Nootropics market: Form movement analysis, 2024 & 2030 (%)
- Fig. 11 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 12 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 13 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 14 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 15 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 16 U.S. Nootropics market: Application movement analysis, 2024 & 2030 (%)
- Fig. 17 U.S. Nootropics market estimates and forecast for cognitive enhance, 2018 - 2030 (USD Million)
- Fig. 18 U.S. Nootropics market estimates and forecast for mood & stress management, 2018 - 2030 (USD Million)
- Fig. 19 U.S. Nootropics market estimates and forecast for sleep optimization, 2018 - 2030 (USD Million)
- Fig. 20 U.S. Nootropics market estimates and forecast for energy & physical performance, 2018 - 2030 (USD Million)
- Fig. 21 U.S. Nootropics market estimates and forecast for others, 2018 - 2030 (USD Million)
- Fig. 22 U.S. Nootropics market: Distribution channel movement analysis, 2024 & 2030 (%)
- Fig. 23 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 24 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)
